Descriptor English: | Iohexol | ||||
Descriptor Spanish: |
Yohexol
| ||||
Descriptor Portuguese: | Iohexol | ||||
Descriptor French: | Iohexol | ||||
Entry term(s): |
Compound 545 Exypaque Iohexol 350 Nycodenz Omnipaque |
||||
Tree number(s): |
D02.241.223.100.400.880.400 D02.455.426.559.389.127.375.880.400 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007472 | ||||
Scope note: | An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AN analysis CH chemistry CL classification CS chemical synthesis EC economics HI history IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use |
||||
Pharm Action: |
Contrast Media |
||||
Registry Number: | 4419T9MX03 | ||||
CAS Type 1 Name: | 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- | ||||
Previous Indexing: |
Triiodobenzoic Acids (1972-1986) |
||||
Public MeSH Note: | 87 |
||||
History Note: | 87 |
||||
DeCS ID: | 19218 | ||||
Unique ID: | D007472 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1987/01/01 | ||||
Date of Entry: | 1986/06/03 | ||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Iohexol
- Preferred
Nycodenz
- Narrower
Compound 545
- Narrower
Exypaque
- Narrower
Omnipaque
- Narrower
Concept UI |
M0011673 |
Scope note | An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. |
Preferred term | Iohexol |
Entry term(s) |
Iohexol 350 |
Concept UI |
M0351688 |
Preferred term | Nycodenz |
Concept UI |
M0351690 |
Preferred term | Compound 545 |
Concept UI |
M0351689 |
Preferred term | Exypaque |
Concept UI |
M0351687 |
Preferred term | Omnipaque |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey